Quantcast

Tag Archives: pharmaceuticals

Baltimore County to file federal lawsuit against opioid manufacturers

Kevin Kamenetz

Baltimore County is poised to become the second Maryland jurisdiction to sue pharmaceutical manufacturers and distributors of opioids, alleging the industry pressured doctors to over-prescribe drugs and misrepresented the risk of addiction. County Executive Kevin Kamenetz announced the intended lawsuit ...

Read More »

CASI losses continued in 4th quarter

Rockville-based CASI Pharmaceuticals, Inc. reported a net loss of $1.6 million in its fourth-quarter numbers compared to a loss of $1.6 million for the same period last year. CASI, which develops therapeutics for cancer and other unmet medical needs for ...

Read More »

Sucampo expands deal with Japanese firm

Sucampo Pharmaceuticals Inc., of Bethesda, has reached a deal with Takeda Pharmaceutical Co. Ltd., of Japan, for expanded licensing, development and supplying of Amitiza, Sucampo’s  treatment for chronic idiopathic constipation and opioid-induced constipation, the companies announced. Takeda has obtained global ...

Read More »

RegeneRx nears eye-drop trials

RegeneRx Biopharmaceuticals Inc., of Rockville, may start clinical trials of a treatment for neurotrophic keratopathy, a disease of the cornea, within a year, the company announced. RegeneRx said it met with the Food and Drug Administration in September and as ...

Read More »

EntreMed reports higher loss in 4Q

EntreMed Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, reported a fourth-quarter net loss of $1.3 million.

Read More »